1. Home
  2. ARWR vs PRVA Comparison

ARWR vs PRVA Comparison

Compare ARWR & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • PRVA
  • Stock Information
  • Founded
  • ARWR 2003
  • PRVA 2007
  • Country
  • ARWR United States
  • PRVA United States
  • Employees
  • ARWR N/A
  • PRVA N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • PRVA Retail: Computer Software & Peripheral Equipment
  • Sector
  • ARWR Health Care
  • PRVA Technology
  • Exchange
  • ARWR Nasdaq
  • PRVA Nasdaq
  • Market Cap
  • ARWR 2.6B
  • PRVA 2.8B
  • IPO Year
  • ARWR 1993
  • PRVA 2021
  • Fundamental
  • Price
  • ARWR $19.90
  • PRVA $24.52
  • Analyst Decision
  • ARWR Buy
  • PRVA Strong Buy
  • Analyst Count
  • ARWR 11
  • PRVA 17
  • Target Price
  • ARWR $43.33
  • PRVA $24.71
  • AVG Volume (30 Days)
  • ARWR 2.5M
  • PRVA 587.6K
  • Earning Date
  • ARWR 02-10-2025
  • PRVA 02-27-2025
  • Dividend Yield
  • ARWR N/A
  • PRVA N/A
  • EPS Growth
  • ARWR N/A
  • PRVA N/A
  • EPS
  • ARWR N/A
  • PRVA 0.11
  • Revenue
  • ARWR $2,500,000.00
  • PRVA $1,716,318,000.00
  • Revenue This Year
  • ARWR $3,336.78
  • PRVA $78.50
  • Revenue Next Year
  • ARWR $124.29
  • PRVA $11.52
  • P/E Ratio
  • ARWR N/A
  • PRVA $227.34
  • Revenue Growth
  • ARWR N/A
  • PRVA 8.54
  • 52 Week Low
  • ARWR $17.05
  • PRVA $15.92
  • 52 Week High
  • ARWR $36.72
  • PRVA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 49.40
  • PRVA 61.94
  • Support Level
  • ARWR $17.57
  • PRVA $23.49
  • Resistance Level
  • ARWR $21.84
  • PRVA $25.67
  • Average True Range (ATR)
  • ARWR 1.06
  • PRVA 0.75
  • MACD
  • ARWR 0.11
  • PRVA 0.06
  • Stochastic Oscillator
  • ARWR 54.57
  • PRVA 64.72

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About PRVA Privia Health Group Inc.

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Share on Social Networks: